Delivery Order SPE2DX22D0010-SPE2D825FFD13
Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Vyvanse capsules 40mg, valued at approximately $25.9K. This non-competitive delivery order, with a firm fixed price structure, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $13,562.15 to AmerisourceBergen Drug Corp for Vyvanse 50mg capsules. This firm fixed-price contract, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse capsules (50mg) valued at $12,583.48 under a firm fixed-price contract. The award was made on November 4, 2025, with an ultimate completion date of November 5, 2025, with no set-aside designation. The order will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical...
- The Department of Defense's Medical Supply Chain awarded a $26,751.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (50mg) on October 3, 2025, with an ultimate completion date of October 6, 2025. This non-compete, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Vyvanse capsules (50mg) valued at $21,014.83. This competitively awarded, firm fixed-price delivery order is set to be completed by November 6, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,360.56 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100-count units) under a firm fixed-price contract. The order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order is a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,658.76 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (30 mg) on August 20, 2025. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, leveraging...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $4,904.90 to AmerisourceBergen Drug Corp for the supply of Vyvanse 10mg tablets (100 count) on August 26, 2025, with a completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,167.14 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg on August 27, 2025. This competitively awarded, firm fixed price contract represents a single delivery order with an ultimate completion date of August 28, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,679.97 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...